Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Derek D, Dunn"'
Autor:
Babu G, Sundar, Thomas R, Bailey, Derek D, Dunn, Edward R, Bacon, Joseph M, Salvino, George C, Morton, Lisa D, Aimone, Huang, Zeqi, Joanne R, Mathiasen, Amy, Dicamillo, Mark J, Huffman, Beth A, McKenna, Karla, Kopec, Lily D, Lu, Rebecca, Brown, Jie, Qian, Thelma, Angeles, Thomas, Connors, Chrysanthe, Spais, Beverly, Holskin, Deborah, Galinis, Emir, Duzic, Herve, Schaffhauser, Gerard C, Rosse
Publikováno v:
Bioorganicmedicinal chemistry letters. 22(1)
7-Arylsulfonyl substituted benzofuropiperidine was discovered as a novel scaffold for 5HT(6) receptor antagonists. Optimization by substitution at C-1 position led to identification of selective, orally bioavailable, brain penetrant antagonists with
Autor:
Dahir KM; Program for Metabolic Bone Disorders, Vanderbilt University Medical Center, Nashville, TN, United States., Shannon A; Development, Regulatory and Safety, Alexion, AstraZeneca Rare Disease, Boston, MA, United States., Dunn D; Development, Regulatory and Safety, Alexion, AstraZeneca Rare Disease, Boston, MA, United States., Voegtli W; Development, Regulatory and Safety, Alexion, AstraZeneca Rare Disease, Boston, MA, United States., Dong Q; Development, Regulatory and Safety, Alexion, AstraZeneca Rare Disease, Boston, MA, United States., Hasan J; Development, Regulatory and Safety, Alexion, AstraZeneca Rare Disease, Boston, MA, United States., Pradhan R; Development, Regulatory and Safety, Alexion, AstraZeneca Rare Disease, Boston, MA, United States., Pelto R; Bioanalytical and Biomarker Development, Alexion, AstraZeneca Rare Disease, New Haven, CT, United States., Pan WJ; Development, Regulatory and Safety, Alexion, AstraZeneca Rare Disease, Boston, MA, United States.
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2024 Aug 13. Date of Electronic Publication: 2024 Aug 13.
Autor:
Duenas DC; Department of Civil and Environmental Engineering, University of California, Irvine, California 92697-2175, United States., Dunn-Rankin D; Department of Civil and Environmental Engineering, University of California, Irvine, California 92697-2175, United States.; Department of Mechanical and Aerospace Engineering, University of California, Irvine, California 92697-3975, United States., Chien YC; Department of Mechanical and Aerospace Engineering, University of California, Irvine, California 92697-3975, United States.
Publikováno v:
Energy & fuels : an American Chemical Society journal [Energy Fuels] 2024 Apr 15; Vol. 38 (9), pp. 7862-7872. Date of Electronic Publication: 2024 Apr 15 (Print Publication: 2024).
Autor:
Annane D; Department of Intensive Care, Raymond Poincaré Hospital (Assistance Publique-Hôpitaux de Paris), Garches, France; School of Medicine Simone Veil, University of Versailles Saint Quentin, University Paris-Saclay, Versailles, France; FHU SEPSIS, University Paris-Saclay, INSERM, Garches, France., Pittock SJ; Department of Neurology, Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA., Kulkarni HS; Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA., Pickering BW; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA., Khoshnevis MR; Department of Medicine, Center for Critical Care, Houston Methodist Hospital, Houston, TX, USA., Siegel JL; Department of Critical Care Medicine, Mayo Clinic, Jacksonville, FL, USA., Powell CA; Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Castro P; Medical Intensive Care Unit, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain., Fujii T; Intensive Care Unit, Jikei University Hospital, Tokyo, Japan., Dunn D; Alexion, AstraZeneca Rare Disease, Boston, MA, USA., Smith K; Alexion, AstraZeneca Rare Disease, Boston, MA, USA., Mitter S; Alexion, AstraZeneca Rare Disease, Boston, MA, USA., Kazani S; Alexion, AstraZeneca Rare Disease, Boston, MA, USA., Kulasekararaj A; Department of Haematological Medicine, King's College Hospital, National Institute of Health Research/Wellcome King's Clinical Research Facility and King's College London, London, UK. Electronic address: austin.kulasekararaj@nhs.net.
Publikováno v:
The Lancet. Respiratory medicine [Lancet Respir Med] 2023 Dec; Vol. 11 (12), pp. 1051-1063. Date of Electronic Publication: 2023 Mar 20.
Autor:
Annane D; Department of Intensive Care, Raymond Poincaré Hospital, Assistance Publique-Hôpitaux de Paris, Garches, France; School of Medicine Simone Veil, University of Versailles Saint Quentin, University Paris-Saclay, Versaillles, France; Fédération Hospitalo-Universitaire SEPSIS, University Paris-Saclay, INSERM, Garches, France., Pittock SJ; Department of Neurology, Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA., Dunn D; Alexion, AstraZeneca Rare Disease, Boston, MA, USA., Kulasekararaj A; Department of Haematological Medicine, King's College Hospital, National Institute of Health Research, Wellcome King's Clinical Research Facility, King's College London, London SE5 9RS, UK. Electronic address: austin.kulasekararaj@nhs.net.
Publikováno v:
The Lancet. Respiratory medicine [Lancet Respir Med] 2023 Sep; Vol. 11 (9), pp. e81. Date of Electronic Publication: 2023 Jun 09.
Autor:
Dunayevskiy I; Opto-Knowledge Systems, Inc (OKSI), 19805 Hamilton Ave., Torrance, CA 90502, USA., Kriesel J; Opto-Knowledge Systems, Inc (OKSI), 19805 Hamilton Ave., Torrance, CA 90502, USA., Biasioli A; Mechanical and Aerospace Engineering, University of California, Irvine (UCI), 4200 Engineering Gateway, Irvine, CA 92697, USA., Chien YA; Mechanical and Aerospace Engineering, University of California, Irvine (UCI), 4200 Engineering Gateway, Irvine, CA 92697, USA., Dunn-Rankin D; Mechanical and Aerospace Engineering, University of California, Irvine (UCI), 4200 Engineering Gateway, Irvine, CA 92697, USA., Muzio L; Fossil Energy Research Corporation (FERCo), 23342C South Pointe Dr., Laguna Hills, CA 92653, USA., Himes R; Electric Power Research Institute (EPRI), 3420 Hillview Ave, Palo Alto, CA 94304, USA.
Publikováno v:
Data in brief [Data Brief] 2023 Mar 21; Vol. 48, pp. 109066. Date of Electronic Publication: 2023 Mar 21 (Print Publication: 2023).
Autor:
Saeidi N; Civil and Environmental Engineering Department, University of California, Irvine, USA. saeidin@uci.edu., Dunn-Rankin D; Civil and Environmental Engineering Department, University of California, Irvine, USA. saeidin@uci.edu.; Mechanical and Aerospace Engineering Department, University of California, Irvine, USA., Kvamme B; Hyzen Energy, 26701 Quail Creek, Laguna Hills, CA, 92656, USA., Chien YC; Mechanical and Aerospace Engineering Department, University of California, Irvine, USA.
Publikováno v:
Physical chemistry chemical physics : PCCP [Phys Chem Chem Phys] 2021 Oct 20; Vol. 23 (40), pp. 23313-23324. Date of Electronic Publication: 2021 Oct 20.
Autor:
Wells-Knecht KJ; Teva Pharmaceutical, West Chester, Pennsylvania 19380. Electronic address: kevin.wells-knecht@tevapharm.com., Dunn D; Teva Pharmaceutical, West Chester, Pennsylvania 19380.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2019 Sep; Vol. 108 (9), pp. 3152-3155. Date of Electronic Publication: 2019 May 17.
Publikováno v:
Applied optics [Appl Opt] 2018 Jan 10; Vol. 57 (2), pp. 197-207.
Publikováno v:
Applied optics [Appl Opt] 2017 May 01; Vol. 56 (13), pp. 3736-3743.